Skip to content

Real-world clinical demonstration and extension research on Mongolian medicine brain-white pulse regulating acupuncture in the treatment of Sa Disease (Mongolian Medicine term for stroke)during convalescence

Real-world clinical demonstration and extension research on Mongolian medicine brain-white pulse regulating acupuncture in the treatment of Sa Disease (Mongolian Medicine term for stroke)during convalescence

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2024000868
Enrollment
Unknown
Registered
2024-12-25
Start date
2024-12-31
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive impairment after stroke

Interventions

Gala Sa:none
Wu Sun Sa:none

Sponsors

International Mongolian Hospital of Inner Mongolia
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Diagnosis of stroke during the recovery phase in accordance with the "Guidelines and Consensus for the Diagnosis and Treatment of Cerebrovascular Diseases in China (2016 Edition)" confirmed by cranial CT or MRI or consistent with the diagnosis and classification of "Encyclopedia of Chinese Medicine - Mongolian Medicine Volume (1986 Edition)" for Sar disease with lesions confined to the cerebral hemisphere; 2) Onset 2 weeks to 6 months prior; 3) Clear consciousness and stable vital signs; 4) Age between 18 and 75 years inclusive 5)Those who have signed the treatment consent form.

Exclusion criteria

Exclusion criteria: 1) Patients with stroke indicated by cranial CT or MRI in the brainstem or cerebellum; 2) Individuals with consciousness disorders, unstable vital signs, or quadriplegia; 3) Patients with concomitant hemolytic diseases, thrombocytopenic disorders, or malignant tumors; 4) Individuals with severe musculoskeletal diseases (affecting limb weight-bearing) or severe heart, lung, or kidney dysfunction; 5) Patients with severe post-stroke depression, sensory aphasia, mental disorders, or severe dementia.

Design outcomes

Primary

MeasureTime frame
Hoffer Walking Ability Scale;Fugl-Meyer;Ashworth;NIHSS;

Secondary

MeasureTime frame
Berg Balance Scale (BBS);Addenbrooke;Watanabe Classification;Chinese Standard Aphasia Screening Test;FIM (Functional Independence Measure) scale;

Countries

China

Contacts

Public ContactYaohasi

International Mongolian Hospital of Inner Mongolia

Yaohasi@126.com13848150360

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026